| [1] |
World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021[R/OL]. (2021⁃07⁃15)[2026⁃02⁃05]. https://www.who.int/publications/i/item/9789240027077.
|
| [2] |
卢文杰, 梁诗晴, 岳晓丽, 等. 2018—2023年中国淋病流行趋势及时空分布特征[J]. 中华皮肤科杂志, 2024,57(5):445⁃449. DOI: 10.35541/cjd.20240034.
|
| [3] |
Cyr SS, Barbee L, Workowski KA, et al. Update to CDC's treatment guidelines for gonococcal infection, 2020[J]. MMWR Morb Mortal Wkly Rep, 2020,69(50):1911⁃1916. DOI: 10.15585/ mmwr.mm6950a6.
|
| [4] |
中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会. 梅毒、淋病和生殖道沙眼衣原体感染诊疗指南(2020年)[J]. 中华皮肤科杂志, 2020,53(3):168⁃179. DOI: 10.35541/ cjd.20190808.
|
| [5] |
Chen S, Yuan L, Zhu X, et al. Sustained transmission of the ceftriaxone⁃resistant Neisseria gonorrhoeae FC428 clone in China[J]. J Antimicrob Chemother, 2020,75(9):2499⁃2502. DOI: 10.1093/jac/dkaa196.
|
| [6] |
Yuan Q, Li Y, Xiu L, et al. Identification of multidrug⁃resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018[J]. Emerg Microbes Infect, 2019,8(1):1546⁃1549. DOI: 10.1080/22221751. 2019.1681242.
|
| [7] |
Büyükkiraz ME, Kesmen Z. Antimicrobial peptides (AMPs): a promising class of antimicrobial compounds[J]. J Appl Microbiol, 2022,132(3):1573⁃1596. DOI: 10.1111/jam.15314.
|
| [8] |
Tanphaichitr N, Srakaew N, Alonzi R, et al. Potential use of antimicrobial peptides as vaginal spermicides/microbicides[J]. Pharmaceuticals (Basel), 2016,9(1):13. DOI: 10.3390/ph9010013.
|
| [9] |
John CM, Li M, Feng D, et al. Cationic cell⁃penetrating peptide is bactericidal against Neisseria gonorrhoeae[J]. J Antimicrob Chemother, 2019,74(11):3245⁃3251. DOI: 10.1093/jac/dkz339.
|
| [10] |
Tang L, Chen J, Zhou Z, et al. Chlamydia⁃secreted protease CPAF degrades host antimicrobial peptides[J]. Microbes Infect, 2015,17(6):402⁃408. DOI: 10.1016/j.micinf.2015.02.005.
|
| [11] |
Sambri V, Marangoni A, Giacani L, et al. Comparative in vitro activity of five cathelicidin⁃derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum[J]. J Antimicrob Chemother, 2002,50(6):895⁃902. DOI: 10.1093/jac/dkf220.
|
| [12] |
Ridyard KE, Overhage J. The potential of human peptide LL⁃37 as an antimicrobial and anti⁃biofilm agent[J]. Antibiotics (Basel), 2021,10(6):650. DOI: 10.3390/antibiotics10060650.
|
| [13] |
Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug⁃ and extensively drug⁃resistant Neisseria gonorrhoeae[J]. Expert Rev Anti Infect Ther, 2009,7(7):821⁃834. DOI: 10.1586/eri.09.63.
|
| [14] |
World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae[R/OL]. (2012⁃05⁃04)[2026⁃02⁃05]. https://www.who.int/publications/i/item/9789241503501.
|
| [15] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 32nd ed. CLSI supplement M100[S/OL]. Wayne: CLSI,2022.[2026⁃02⁃05]. https://www.standards⁃global.com/wp⁃content/uploads/pdfs/preview/2247002.
|
| [16] |
European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0[S/OL]. Sweden:EUCAST,2015. (2015⁃12⁃31)[2026⁃02⁃05]. https://www.eucast.org/fileadmin/eucast/pdf/Document_Archive/bacteria/breakpoint_tables/v_5.0_Breakpoint_Table_01.xls.
|
| [17] |
Balduck M, Laumen JGE, Abdellati S, et al. Tolerance to ceftriaxone in Neisseria gonorrhoeae: rapid induction in WHO P reference strain and detection in clinical isolates[J]. Antibiotics (Basel), 2022,11(11):1480. DOI: 10.3390/antibiotics11111480.
|
| [18] |
Long DR, Mead J, Hendricks JM, et al. 18β⁃Glycyrrhetinic acid inhibits methicillin⁃resistant Staphylococcus aureus survival and attenuates virulence gene expression[J]. Antimicrob Agents Chemother, 2013,57(1):241⁃247. DOI: 10.1128/AAC.01023⁃12.
|
| [19] |
Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances[J]. Nat Protoc, 2008,3(2):163⁃175. DOI: 10.1038/nprot.2007.521.
|
| [20] |
White RL, Burgess DS, Manduru M, et al. Comparison of three different in vitro methods of detecting synergy: time⁃kill, checkerboard, and E test[J]. Antimicrob Agents Chemother, 1996,40(8):1914⁃1918. DOI: 10.1128/AAC.40.8.1914.
|
| [21] |
Kiattiburut W, Zhi R, Lee SG, et al. Antimicrobial peptide LL⁃37 and its truncated forms, GI⁃20 and GF⁃17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae[J]. Hum Reprod, 2018,33(12):2175⁃2183. DOI: 10.1093/humrep/dey315.
|
| [22] |
Miyoshi N, Isogai E, Hiramatsu K, et al. Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug⁃resistant Staphylococcus aureus[J]. J Antibiot (Tokyo), 2017,70(2):142⁃146. DOI: 10.1038/ja.2016.101.
|
| [23] |
Lee SG, Kiattiburut W, Schinkel SCB, et al. Safety of multiple administrations of spermicidal LL⁃37 antimicrobial peptide into the mouse female reproductive tract[J]. Mol Hum Reprod, 2023,29(7):gaad023. DOI: 10.1093/molehr/gaad023.
|